Take2

Take2 is a provider of an AI agents platform purpose-built for healthcare recruiting. From its funding announcement.

$14M Series ARaised 8 months agoNYC, USAHealthcare & MedtechUSA

In their own words

What Take2 says it is doing

Work here? Claim your company profile

Public signal Described in the funding announcement as "provider of an AI agents platform purpose-built for healthcare recruiting". Source

HiringProduct

Public signal Read from the company's own description of what the funding supports.

Why now

Where Take2 is today

Take2 announced a Series A round of $14M on 11 February 2026.

Latest round
Series A
Amount
$14M
Announced
11 February 2026
Headquarters
NYC, USA
Sector
Healthcare & Medtech
Investors
Not stated
Also participating
Not stated
Relevant leadership
Not stated

Momentum AfterRaise intelligence

AfterRaise Score

36
Established
0 funding signals in the last 90 days
Funding recency
9/40
announced within the last year
Round scale
12/25
round size relative to the market
Funding stage
15/20
Series A
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Since the raise

What has happened since

  • 11 February 2026
    $14M Series A
    Investors not stated in the announcement.

Public signal The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

What may happen next

What this raise could create

AfterRaise intelligenceNot a statement of fact

What may happen next

  • Team growth across core functions
  • Senior leadership appointments
  • Product launches and new tiers
  • Product leadership hiring

Opportunities this could create

  • Provider partnerships
  • Executive search
  • Talent partners
  • Employer infrastructure
  • Product leadership

Based on the Healthcare & Medtech sector, a Series A round and the priorities the company itself set out. Not a statement of fact.

Early momentum3 connected signals
  • 11 February 2026$14M Series A announced
  • 11 February 2026Stated priority: hiring
  • 11 February 2026Stated priority: product

High momentum means several meaningful company changes have occurred in a short period. Signals here are funding events and the priorities the company stated; hiring, leadership and expansion detection join with the signals layer.

Open to

What Take2 is open to

Not yet specified

Take2 has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Opportunities

Ways to work with Take2

No open opportunities listed

Jobs, projects, partnerships, advisory and supplier needs appear here once the company has claimed its page and published them, and any role we read from its own job board appears automatically.

Work here? Open the first one

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Do you work at Take2?

Claim your company profile.

This page was created from publicly available information. A verified representative corrects the record, says what the company is building next and chooses which conversations it welcomes.

What we do not have yet: your website, the roles and projects you have open and who leads the team. Claiming the page is how you fill those in.

Someone else requesting access does not give them ownership. Every representative is verified by a person before access is granted.

Maintaining your own company profile is free. A founder, CEO or authorised senior colleague can represent the company.

Also moving

Other Healthcare & Medtech companies

See the sector